Skip to main content
. 2020 Oct 8;3(1):100190. doi: 10.1016/j.jhepr.2020.100190

Table 5.

Uni- and multivariable analysis of variables associated with a textbook outcome.

Variable Textbook outcomes
Univariate p value Multivariate p value [OR (95% CI)]
Yes (n = 27) No (n = 52)
Age (years) 64 (59–71) 66 (44–69) 0.59
Male sex 21 (78) 44 (85) 0.45
Body mass index (kg/m2) 27 (24–30) 30 (26–32) 0.19
ASA score >2 14 (52) 24 (46) 0.63
Virus-related cirrhosis 16 (59) 34 (65) 0.59
Previous treatment 4 (15) 14 (27) 0.22
Repeat hepatectomy 1 (4) 1 (2) 0.63
Child-Pugh class B 0 (0) 1 (2) 0.47
HVPG (mmHg) 11 (10–14) 12 (11–16) 0.13
Indirect signs of CSPH 12 (44) 19 (37) 0.49
Oesophageal varices 10 (37) 16 (31) 0.57
Splenomegaly and thrombopenia 4 (15) 8 (15) 0.95
MELD score 8 (6–9) 8 (6–9) 0.57
Creatinine (μmol/L) 84 (70–91) 78 (67–97) 0.48
Total Bilirubin (μmol/L) 11 (8–15) 14 (9–19) 0.06 0.21
Albumin (g/L) 42 (39–44) 39 (36–42) 0.05 0.43
Platelet (105/mm3) 127 (96–167) 134 (104–164) 0.30
Portal vein embolisation 0 (0) 5 (10) 0.10 0.99
Major resection 1 (4) 13 (25) 0.02 0.70
Laparoscopic approach 10 (37) 42 (81) 0.0001 0.003 [7.2 (2.0–25.6)]
Anatomical resection 14 (52) 30 (58) 0.62
Associated procedures 1 (4) 7 (13) 0.17
Inflow clamping 6 (22) 7 (13) 0.32
Operative time (min) 230 (180–293) 240 (188–334) 0.17
High grade of technical difficulty 8 (30) 27 (52) 0.06 0.13

Results are presented as median (interquartile range) or n (%).

ASA, American Society of Anesthesiologists; CSPH, clinically significant portal hypertension; HVPG, hepatic venous pressure gradient; MELD, Model for End-Stage Liver Disease; OR, odds ratio.